Related Experiment Video

Updated: Jun 26, 2025

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

14.4K

Project Optimus Elicits the "Holistic" Benefits of PK/PD Modeling of Immunotherapy

Mathangi Gopalakrishnan1, Rodabe N Amaria2

  • 1Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, Maryland.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|May 14, 2024
PubMed

More Related Videos

Creation and Maintenance of a Living Biobank - How We Do It13:08

Creation and Maintenance of a Living Biobank - How We Do It

Published on: April 10, 2021

7.4K
Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry08:30

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

12.3K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518